Just-Evotec Biologics
Clinical trials sponsored by Just-Evotec Biologics, explained in plain language.
Now part of
Evotec SE
EVT
XETRA
Biologics contract development and manufacturing, subsidiary of Evotec.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New antibody combo JST-018 enters first human safety trial Results expected Nov 2026 (estimated)
- New shot aims to stop the plague before it starts Results expected Apr 2027 (estimated)